Article
Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate…
medRxiv · 2022 · Peddireddy, S. P.; Rahman, S. A.; Cillo, A. R.; Vijay, G. M.; Somasundaram, A.; Workman, C. J.; Bain, W.; McVerry, B. J.; Methe, B.; Lee, J. S.; Ray, P.; Ray, A.; Bruno, T. C.; Vignali, D. A.; Kitsios, G. D.; Morris, A.; Singh, H.; Sarkar, A.; Das, J.
Key facts
| Title | Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19 |
|---|---|
| First author | Peddireddy, S. P.; Rahman, S. A.; Cillo, A. R.; Vijay, G. M.; Somasundaram, A.; Workman, C. J.; Bain, W.; McVerry, B. J.; Methe, B.; Lee, J. S.; Ray, P.; Ray, A.; Bruno, T. C.; Vignali, D. A.; Kitsios, G. D.; Morris, A.; Singh, H.; Sarkar, A.; Das, J. |
| Journal | medRxiv |
| Published | Feb 15, 2022 |
| DOI | 10.1101/2022.01.24.477545 |
| Devices mentioned | K121894 |
| Product codes mentioned | NSU, PCH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1